Headquartered in Alameda, California, it is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures, and markets new products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet needs. Penumbra provides support to healthcare providers, hospitals, and clinics in over 100 countries.
Institutional videos
Listen to Dr. Charles Matouk discuss the evolution of stroke treatment, how the COMPLETE study impacted Yale’s first ADAPT stroke practice, and why RED is his catheter of choice.
Acute Ischemic Stroke
(Story 1)
The opinions and clinical experiences presented here are for informational purposes only. The results may not be predictive for all patients. Individual results may vary depending on a variety of patient-specific attributes. Any treatment decision should be made in consultation with a healthcare professional based on a thorough discussion of the risks and benefits. The views and opinions expressed here are those of the interviewee and do not necessarily reflect the views of Penumbra, Inc. or its affiliates. The doctor featured is a consultant for Penumbra, Inc.